4-BROMOISOXAZOLE-3-CARBOXYLIC ACID, 95%, 500mg

(S)-4-Phenyl-2-(2-((R)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole, 95%, 100mg

Benzimidazole-6-thiocarboxamide, 250mg

6-Fluoro-3,4-dihydro-1(2H)-isoquinolinone, 95.0%, 25g

1-Ethylcyclopentanol>96.0%(GC)25g

Gefitinib-based PROTAC 3, 10mg

1,1,1-Trifluoro-2-propanol, 90.0%, 1g

Pyrrolidine-2-carboximidamide dihydrochloride, 95%, 5g

4-Amino-3-formylpyridine, 98.0%, 250mg

3-(Chloromethyl)-2-methylpyridine, 95.0%, 250mg

Tetrabutylammonium Fluoride (70-75% in Water)100g

2-(4,6-Dimethoxypyrimidin-2-yl)cyclohexanecarboxylic acid, 95.0%, 1g

4-Aminocrotonic Acid Hydrochloride, 97% HPLC, 10mg